DJIA 17,098.45 18.88 0.11%
NASDAQ 4,580.27 0.00 0.00%
S&P 500 2,003.37 6.63 0.33%
market minute promo

Omeros (NASDAQ: OMER)

14.91 0.72 (5.07%)

REAL-TIME: Last trade at


company name or ticker

Recent Quotes

OMER $14.91 5.07%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $14.19
Previous Close $14.19
Daily Range $13.95 - $14.99
52-Week Range $4.95 - $18.80
Market Cap $506.9M
P/E Ratio -9.50
Dividend (Yield) $0.00 (0.0%)
Volume 363,443
Average Daily Volume 253,904
Current FY EPS -$2.33

Sector

Healthcare

Industry

Drugs

Omeros (OMER) Description

Omeros Corporation is a clinical-stage Biopharmaceutical Company engaged in discovering developing and commercializing products focused on inflammation and disorders of the central nervous system. Website: http://www.omeros.com/

News & Commentary

2 Small-Cap Biotechs for Your Watchlist

Omeros and Dynavax each have drugs that could produce huge gains. Risk of investment is also mitigated by certain factors in each company.

Omeros Corporation Estimates May Vary

Omeros (OMER) Enters Overbought Territory - Tale of the Tape

Omeros Corporation (OMER) Gains: Stock Up 8.92% - Tale of the Tape

Omeros Corporation (OMER) Gains: Stock Up 8.92% - Tale of the Tape

Qualifying Speculation In Omeros Corporation

Omeros (OMER) Enters Overbought Territory - Tale of the Tape

Omeros' Omidria Gets FDA Nod - Analyst Blog

Monday’s Top Biotech Stories: Ariad, Omeros, NPS Pharmaceuticals, and Shire

Ariad, Omeros, NPS Pharmaceuticals, and Shire could all loom large in health care headlines this Monday morning.

Benzinga's Top #PreMarket Gainers

2nd Half Of 2014 Biotechnology Catalysts: Part 1

See More OMER News...

OMER's Top Competitors

OMER $14.91 (5.07%)
Current stock: OMER
AMGN $139.38 (0.50%)
Current stock: AMGN
GILD $107.56 (0.05%)
Current stock: GILD
BIIB $343.04 (0.53%)
Current stock: BIIB